CTLA-4 can inhibit the proliferation of T cells mainly in lymph nodes at the initial stage of the immune response, while PD-1 plays a crucial role in peripheral tissues including tumor tissue by suppressing previously activated T cells at the later stages of this response (53). The gene discussed is CTLA4; the disease is neoplasm.